Methods of conditioning patients for t cell therapy
US-2018369283-A1 · Dec 27, 2018 · US
US10500253B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10500253-B2 |
| Application number | US-201615541126-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 5, 2016 |
| Priority date | Jan 5, 2015 |
| Publication date | Dec 10, 2019 |
| Grant date | Dec 10, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides compositions and methods for improving reproductive health of mammals and increasing milk production from female mammals. The methods involve administering an effective amount of IL-8 to a female mammal such that the reproductive health of the mammal is improved, or milk production from the mammal is increased, or the fat content of the milk is increased. In another aspect the disclosure includes prophylaxis and/or therapy of uterine conditions by administering IL-8 to a female mammal.
Opening claim text (preview).
What is claimed is: 1. A method for inhibiting the development of puerperal metritis in a non-human female mammal comprising administering to the female mammal an effective amount of Interleukin-8 (IL-8), wherein the female mammal is within twenty weeks post parturition when the IL-8 is administered. 2. The method of claim 1 , wherein the administration of the IL-8 is an intrauterine administration or an intravaginal administration. 3. The method of claim 1 , wherein the female mammal is a member of a population of female mammals of the same species, the method further comprising administering the IL-8 to other members of the population within twenty weeks post parturition, such that inhibition of the development of puerperal metritis occurs in the other members subsequent to the administration. 4. The method of claim 1 , wherein the mammal is a bovine mammal. 5. The method of claim 4 , wherein the bovine mammal is a dairy cow.
for lactation disorders, e.g. galactorrhoea · CPC title
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Polymeric derivatives, e.g. peptides or proteins · CPC title
IL-8 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.